Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
HeMemics Biotechnologies, Inc
United States
- Gaithersburg, Maryland
- 26/05/2023
- Seed
- $2,000,000
Hememics uniquely uses graphene-based sensors with our patented bio preservatives to bring handheld, lab-quality testing performance to wherever needed – whether it is a farm, emergency room or battlefield. Our rugged, low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors. Our sensors can be individually programmed to detect molecular, antigen and antibody targets. We put a whole lab in your hand so you can make decisions when and wherever necessary – simplifying workflows with results within minutes.
- Industry Biotechnology Research
- Website https://www.hememics.com/
- LinkedIn https://www.linkedin.com/company/hememics-biotechnologies-inc/
Related People
John L. Warden, Jr.Founder
United States -
Chevy Chase, Maryland
Proven record of developing businesses around emerging technologies and new products. Over 25 years experience in business development, sales and capital formation of emerging technology companies.
Sales and business development executive with proven results in identifying, selling, negotiating and closing high-value agreements in pharmaceutical research, big data, chemicals and financial instruments.
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)